Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia

Hdl Handle:
http://hdl.handle.net/10144/311613
Title:
Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia
Authors:
Schramm, Birgit; Valeh, Parastou; Baudin, Elisabeth; Mazinda, Charles S; Smith, Richard; Pinoges, Loretxu; Sundaygar, Timothy; Zolia, Yah M; Jones, Joel J; Comte, Eric; Bruneel, Arnaud; Branger, Michel; Jullien, Vincent; Carn, Gwenaelle; Kiechel, Jean-René; Ashley, Elizabeth A; Guérin, Philippe J
Journal:
Malaria Journal
Abstract:
Safety surveillance of widely used artemisinin-based combination therapy (ACT) is essential, but tolerability data in the over five years age group are largely anecdotal.
Publisher:
BioMed Central
Issue Date:
17-Jul-2013
URI:
http://hdl.handle.net/10144/311613
DOI:
10.1186/1475-2875-12-250
PubMed ID:
23866736
Language:
en
ISSN:
1475-2875
Appears in Collections:
Malaria

Full metadata record

DC FieldValue Language
dc.contributor.authorSchramm, Birgiten_GB
dc.contributor.authorValeh, Parastouen_GB
dc.contributor.authorBaudin, Elisabethen_GB
dc.contributor.authorMazinda, Charles Sen_GB
dc.contributor.authorSmith, Richarden_GB
dc.contributor.authorPinoges, Loretxuen_GB
dc.contributor.authorSundaygar, Timothyen_GB
dc.contributor.authorZolia, Yah Men_GB
dc.contributor.authorJones, Joel Jen_GB
dc.contributor.authorComte, Ericen_GB
dc.contributor.authorBruneel, Arnauden_GB
dc.contributor.authorBranger, Michelen_GB
dc.contributor.authorJullien, Vincenten_GB
dc.contributor.authorCarn, Gwenaelleen_GB
dc.contributor.authorKiechel, Jean-Renéen_GB
dc.contributor.authorAshley, Elizabeth Aen_GB
dc.contributor.authorGuérin, Philippe Jen_GB
dc.date.accessioned2014-01-20T21:32:37Z-
dc.date.available2014-01-20T21:32:37Z-
dc.date.issued2013-07-17-
dc.identifier.citationTolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia. 2013, 12 (1):250 Malar. J.en_GB
dc.identifier.issn1475-2875-
dc.identifier.pmid23866736-
dc.identifier.doi10.1186/1475-2875-12-250-
dc.identifier.urihttp://hdl.handle.net/10144/311613-
dc.description.abstractSafety surveillance of widely used artemisinin-based combination therapy (ACT) is essential, but tolerability data in the over five years age group are largely anecdotal.en_GB
dc.languageENG-
dc.language.isoenen
dc.publisherBioMed Centralen_GB
dc.rightsPublished by BioMed Central, [url]http://www.malariajournal.com/[/url] Archived on this site by Open Access permissionen_GB
dc.subjectMalariaen_GB
dc.subjectPediatricsen_GB
dc.titleTolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberiaen
dc.identifier.journalMalaria Journalen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.